ストックスクリーナーアプリを入手
5.56
9.23%
0.47
前日終値:
$5.09
開ける：
$5.16
24時間の取引高:
1.83M
Relative Volume:
0.64
時価総額：
$382.24M
収益：
-
当期純損益:
$-87.23M
株価収益率:
-1.8721
EPS:
-2.97
ネットキャッシュフロー:
$-82.77M
1週間 パフォーマンス:
+17.30%
1か月 パフォーマンス:
+13.93%
6か月 パフォーマンス:
+286.11%
1年 パフォーマンス:
+28.70%
1日の値動き範囲:
$5.04
$5.74
1週間の範囲:
$4.75
$5.97
52週間の値動き範囲:
$0.8801
$6.85
Pepgen Inc Stock (PEPG) Company Profile
PEPG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
5.56 | 349.93M | 0 | -87.23M | -82.77M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-09 | 開始されました | Guggenheim | Buy |
| 2024-12-16 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2024-07-31 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-12-21 | 開始されました | H.C. Wainwright | Buy |
Pepgen Inc (PEPG) 最新ニュース
Can PepGen Inc. stock beat analyst upgradesMarket Activity Recap & Long-Term Growth Portfolio Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against PepGen Inc. (PEPG) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Why retail investors pile into PepGen Inc. stockDividend Hike & Safe Capital Growth Stock Tips - newser.com
Will PepGen Inc. price bounce be sustainable2025 Growth vs Value & Low Risk Profit Maximizing Plans - newser.com
What risks investors should watch in PepGen Inc. stockMarket Performance Report & Capital Protection Trading Alerts - newser.com
PepGen Inc. (PEPG) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Stockholders to Connect - ACCESS Newswire
PepGen Investor Drops Suit Over Muscular Dystrophy Drug Study - news.bloomberglaw.com
Can PepGen Inc. stock attract ESG capital inflows2025 Trading Volume Trends & Safe Entry Momentum Stock Tips - newser.com
Will PepGen Inc. see short term momentumShort Setup & Safe Entry Momentum Stock Tips - newser.com
Smart tools for monitoring PepGen Inc.’s price actionPortfolio Update Summary & AI Powered Trade Plan Recommendations - newser.com
Advanced analytics toolkit walkthrough for PepGen Inc.2025 Volatility Report & Stepwise Swing Trade Plans - newser.com
Will PepGen Inc. continue its uptrend2025 Trading Recap & Real-Time Chart Pattern Alerts - newser.com
Tools to monitor PepGen Inc. recovery probabilityShare Buyback & Low Drawdown Momentum Ideas - newser.com
Is PepGen Inc. stock trading near support levelsJuly 2025 Big Picture & Weekly High Return Stock Forecasts - newser.com
PepGen (PEPG) Price Target Increased by 17.65% to 10.20 - Nasdaq
Bronstein, Gewirtz & Grossman, LLC Is Investigating PepGen Inc. (PEPG) And Encourages Investors to Connect - ACCESS Newswire
Will PepGen Inc. stock see insider buyingEarnings Overview Report & Safe Investment Capital Preservation Plans - newser.com
PepGen price target raised to $20 from $18 at H.C. Wainwright - MSN
PepGen reports Q3 EPS (52c), consensus (56c) - MSN
PepGen Inc.'s (NASDAQ:PEPG) largest shareholders are individual investors with 39% ownership, private equity firms own 36% - Yahoo Finance
PepGen Inc.Common Stock (NQ: PEPG - FinancialContent
What analysts say about PepGen Inc stockPrice Action Trading & Small Budget Capital Gains - earlytimes.in
Will PepGen Inc. stock sustain high P E ratiosJuly 2025 Summary & High Return Trade Guides - Fundação Cultural do Pará
HC Wainwright & Co. Maintains PepGen (PEPG) Buy Recommendation - Nasdaq
Wedbush Raises Price Target on PepGen to $9 From $8, Keeps Outperform Rating - MarketScreener
PepGen Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - BioSpace
PepGen Narrows Losses And Advances Myotonic Dystrophy Research - Finimize
Pepgen Inc (PEPG) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):